drugset
drugset / Trial / NCT00703677

A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration

NCT00703677 ↗

Phase 1/2 Completed 17 enrolled Westat National Institute of Neurological Disorders and Stroke (NINDS) · collab
NaSingle-groupOpen-labelTreatment

Summary

The goal of this trial is to evaluate the safety and tolerability of lithium in people with progressive supranuclear palsy or corticobasal degeneration.

Timeline

Start
2008-09
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Unknown — —

Indications

corticobasal degeneration disorder progressive supranuclear palsy